In 2011, a respiratory account manager for Novartis Pharmaceuticals brought a False Claims Act lawsuit against his employer, alleging Novartis participated in kickback arrangements with pharmacies in connection with the sale of one of its drugs. The parties recently settled the lawsuit, with Novartis agreeing to pay $390 million. Stipulation and Order of Settlement and Release, United States ex rel. Kester v. Novartis Pharms. Corp., No. 11-cv-8196 (CM) (S.D.N.Y. Mar. 22, 2016), ECF No. 522. For his role in revealing the patient referral kickback scheme, the account manager was awarded $66.4 million.